Getting the Shingrix vaccine after the age of 50 can reduce your chances of developing the painful skin condition known as ...

Q4 2024 Earnings Call Transcript February 20, 2025 Dynavax Technologies Corporation reports earnings inline with expectations ...

Dynavax Technologies Corp (DVAX) reports record revenue for Heplisav-B, advances in vaccine programs, and strategic financial positioning despite rising R&D costs.

GlaxoSmithKline share price has surged more than 36% in two sessions after the announcement of Q3 results. The stock has ...